GlassScriptPhysician profile
Donald P Johnson
NPI 1427141357
$4,484.88
in general payments reported to CMS, 2019-2025
42 companies · $98.95 in 2025
The $98.95 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,105 · 2020: $1,416 · 2021: $1,435 · 2022: $33.51 · 2023: $164 · 2024: $233 · 2025: $98.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $644.28 | 2019-2021 | |
| Novo Nordisk INC | $610.22 | 2019-2021 | |
| Lilly USA, LLC | $362.72 | 2019-2021 | |
| Glaxosmithkline, LLC. | $321.33 | 2019-2024 | Shingrix, Arexvy, Bexsero |
| Pfizer INC. | $309.32 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $214.29 | 2019-2021 | |
| Abbvie INC. | $212.89 | 2020-2021 | |
| Exact Sciences Corporation | $166.79 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $162.32 | 2019-2021 | |
| Allergan, INC. | $146.77 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $140.06 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $129.36 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $89.70 | 2021 | |
| Eisai INC. | $88.00 | 2019-2021 | |
| Dexcom, INC. | $84.21 | 2021-2025 | Dexcom G6 Transmitter |
Show all 41 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$46.56 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.